The journey of a new therapeutic agent from the laboratory to the patient is a meticulous and highly regulated process. Central to this journey are the clinical trials, which are systematically structured to ensure the safety and efficacy of the new treatment. For sponsors, navigating the complexities of phase I II and III clinical trials is a significant undertaking, fraught with...

In clinical research, biostatistics has often been viewed as a final, procedural step: the department that crunches the numbers once all the data is collected. However, this perception is becoming increasingly outdated. Today, biostatistics is a proactive and indispensable strategic partner, shaping the entire lifecycle of a clinical trial from conception to conclusion. Its role has evolved...